1. Home
  2. LFUS vs APGE Comparison

LFUS vs APGE Comparison

Compare LFUS & APGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Littelfuse Inc.

LFUS

Littelfuse Inc.

N/A

Current Price

$417.64

Market Cap

11.7B

Sector

Energy

ML Signal

N/A

Logo Apogee Therapeutics Inc.

APGE

Apogee Therapeutics Inc.

HOLD

Current Price

$135.06

Market Cap

10.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LFUS
APGE
Founded
1927
2022
Country
United States
United States
Employees
N/A
N/A
Industry
Electrical Products
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.7B
10.2B
IPO Year
1996
2023

Fundamental Metrics

Financial Performance
Metric
LFUS
APGE
Price
$417.64
$135.06
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
13
Target Price
$366.67
$109.67
AVG Volume (30 Days)
182.3K
1.3M
Earning Date
05-06-2026
05-12-2026
Dividend Yield
0.77%
N/A
EPS Growth
N/A
N/A
EPS
2.96
N/A
Revenue
$757,853,000.00
N/A
Revenue This Year
$14.65
N/A
Revenue Next Year
$6.98
N/A
P/E Ratio
$139.62
N/A
Revenue Growth
N/A
N/A
52 Week Low
$233.36
$35.39
52 Week High
$500.57
$135.09

Technical Indicators

Market Signals
Indicator
LFUS
APGE
Relative Strength Index (RSI) 44.65 78.58
Support Level $386.67 $134.03
Resistance Level $426.44 N/A
Average True Range (ATR) 15.42 0.10
MACD -1.89 -0.39
Stochastic Oscillator 20.52 96.88

Price Performance

Historical Comparison
LFUS
APGE

About LFUS Littelfuse Inc.

Littelfuse is a supplier of circuit protection products (such as fuses and relays) for the transportation, industrial, telecommunications, and consumer electronics end markets. Littelfuse also holds a minority power semiconductor business, primarily serving high-voltage industrial applications. Littelfuse sells globally across both distribution and direct channels, and organizes its business into the three segments of electronics, transportation, and industrial. Littelfuse is a serial acquirer of smaller, bolt-on adjacent firms.

About APGE Apogee Therapeutics Inc.

Apogee Therapeutics Inc is a clinical-stage biotechnology company engaged in advancing optimized, novel biologics with the potential for differentiated efficacy and dosing in the inflammatory and immunology (I&I) markets, including for the treatment of atopic dermatitis (AD), asthma, eosinophilic esophagitis (EoE), chronic obstructive pulmonary disease (COPD), and other I&I indications. . Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.

Share on Social Networks: